Degranulation of gastrointestinal mast cells contributes to hepatic ischemia–reperfusion injury in mice

The pathological changes following liver damage, including those caused by ischemia and reperfusion (I/R), are closely related to gastrointestinal dysregulation. Mast cells (MCs) are tissue-resident immune cells abundant in the gastrointestinal system that play diverse roles. In view of the characteristic localization of MCs around the microvasculature, we hypothesized that a stimulus-specific set of mediators released through degranulation of gastrointestinal MCs, which are enriched in hepatic sinusoids via the hepatic system, subsequently participate in associated pathological development within the liver. To elucidate the biological role of gastrointestinal MC granules in liver damage, we employed an experimental liver I/R model that allows conditional ablation of MCs. Marked degranulation was detected during I/R, which showed a significant positive correlation with liver damage. Our experiments further disclosed that MC degranulation primarily enhanced the cycle of inflammatory damage in I/R liver consisting of liver sinusoidal endothelial cell death, neutrophil infiltration, and formation of a neutrophil extracellular trap, with a concomitant increase in adhesion molecules, inflammatory cytokines, chemokines, and oxidative stress. Based on the collective results, we propose that suppression of activity or number of MCs may present an effective strategy for protection against hepatic I/R injury.

[1]  E. Daugas,et al.  Early Phase Mast Cell Activation Determines the Chronic Outcome of Renal Ischemia–Reperfusion Injury , 2017, The Journal of Immunology.

[2]  D. Voehringer,et al.  Mucosal mast cells are indispensable for the timely termination of Strongyloides ratti infection , 2016, Mucosal Immunology.

[3]  R. Graham,et al.  IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction , 2016, Proceedings of the National Academy of Sciences.

[4]  M. Tsai,et al.  IgE and mast cells in host defense against parasites and venoms , 2016, Seminars in Immunopathology.

[5]  J. Wood,et al.  Mast Cell: A Multi-Functional Master Cell , 2016, Front. Immunol..

[6]  T. Billiar,et al.  Damage‐associated molecular pattern–activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury , 2015, Hepatology.

[7]  W. D. de Jonge,et al.  The contribution of mast cells to postoperative ileus in experimental and clinical studies , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[8]  M. Tsai,et al.  Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice. , 2015, Journal of visualized experiments : JoVE.

[9]  B. Stanger Cellular homeostasis and repair in the mammalian liver. , 2015, Annual review of physiology.

[10]  S. Frei,et al.  The Multifaceted Mast Cell in Inflammatory Bowel Disease , 2014, Inflammatory bowel diseases.

[11]  K. Jones,et al.  Mast cells in a murine lung ischemia-reperfusion model of primary graft dysfunction , 2014, Respiratory Research.

[12]  L. Dell’Italia,et al.  Chymase Mediates Injury and Mitochondrial Damage in Cardiomyocytes during Acute Ischemia/Reperfusion in the Dog , 2014, PloS one.

[13]  K. Kalimeris,et al.  Global Consequences of Liver Ischemia/Reperfusion Injury , 2014, Oxidative medicine and cellular longevity.

[14]  C. Peralta,et al.  Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. , 2013, Journal of hepatology.

[15]  I. Chapple,et al.  Neutrophil extracellular traps as a new paradigm in innate immunity: friend or foe? , 2013, Periodontology 2000.

[16]  G. Nilsson,et al.  Insights into mast cell functions in asthma using mouse models. , 2013, Pulmonary pharmacology & therapeutics.

[17]  S. Abraham,et al.  Intestinal Mast Cells Mediate Gut Injury and Systemic Inflammation in a Rat Model of Deep Hypothermic Circulatory Arrest* , 2013, Critical care medicine.

[18]  E. Comelli,et al.  Intestinal microbiota in patients with nonalcoholic fatty liver disease , 2013, Hepatology.

[19]  M. Poca,et al.  Transfusion strategies for acute upper gastrointestinal bleeding. , 2013, The New England journal of medicine.

[20]  G. Franck Open access , 2012, Cell cycle.

[21]  Y. Kurata,et al.  Mast cells are not involved in the ischemia-reperfusion injury in perfused rat liver. , 2012, The Journal of surgical research.

[22]  T. Tatlisumak,et al.  Cerebral Mast Cells Mediate Blood-Brain Barrier Disruption in Acute Experimental Ischemic Stroke Through Perivascular Gelatinase Activation , 2011, Stroke.

[23]  C. Kunder,et al.  Mast cell modulation of the vascular and lymphatic endothelium. , 2011, Blood.

[24]  Y. Zhai,et al.  Liver Ischemia and Reperfusion Injury: New Insights into Mechanisms of Innate—Adaptive Immune‐Mediated Tissue Inflammation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  A. Seifalian,et al.  Liver ischemia/reperfusion injury: Processes in inflammatory networks—A review , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  D. Mochly‐Rosen,et al.  Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. , 2010, Circulation.

[27]  N. Robinson,et al.  Primary Graft Dysfunction , 2013, Seminars in Respiratory and Critical Care Medicine.

[28]  M. Karjalainen‐Lindsberg,et al.  Mast Cell Stabilization Reduces Hemorrhage Formation and Mortality After Administration of Thrombolytics in Experimental Ischemic Stroke , 2007, Circulation.

[29]  D. Papaliodis,et al.  Mast Cell Deficient W/Wv Mice Have Lower Serum IL-6 and Less Cardiac Tissue Necrosis Than Their Normal Littermates following Myocardial Ischemia-Reperfusion , 2007, International journal of immunopathology and pharmacology.

[30]  Y. Okayama Mast cell-derived cytokine expression induced via Fc receptors and Toll-like receptors. , 2005, Chemical immunology and allergy.

[31]  Rodney K. Chan,et al.  Mast Cell Protease 5 Mediates Ischemia-Reperfusion Injury of Mouse Skeletal Muscle1 , 2005, The Journal of Immunology.

[32]  Manjeet Singh,et al.  Resident Cardiac Mast Cells and Ischemia-Reperfusion Injury , 2003, Journal of cardiovascular pharmacology and therapeutics.

[33]  A. Lentsch,et al.  Cytokine Cascades and the Hepatic Inflammatory Response to Ischemia and Reperfusion , 2003, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[34]  M. Entman,et al.  Mast cells and macrophages in normal C57/BL/6 mice , 2002, Histochemistry and Cell Biology.

[35]  W. Muller,et al.  Leukocyte-Endothelial Cell Interactions in the Inflammatory Response , 2002, Laboratory Investigation.

[36]  D. Adams,et al.  Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease , 2002, The Lancet.

[37]  K. McMasters,et al.  Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury , 2000, Hepatology.

[38]  H. Jaeschke Reactive oxygen and mechanisms of inflammatory liver injury , 2000, Journal of gastroenterology and hepatology.

[39]  H. Mühl,et al.  Inducible NO synthase: role in cellular signalling. , 1999, The Journal of experimental biology.

[40]  D. Baltimore,et al.  Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor. , 1995, Immunity.

[41]  L. Toledo-Pereyra,et al.  NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURY , 1993, Transplantation.

[42]  P. Ward,et al.  Requirements for neutrophil products and L-arginine in ischemia-reperfusion injury. , 1993, The American journal of pathology.

[43]  Yan Zhang,et al.  Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. , 1992, Science.

[44]  J. Denburg,et al.  'Mucosal' mast cells. , 1984, Immunology today.

[45]  Joakim S. Dahlin,et al.  Mast cell progenitors: origin, development and migration to tissues. , 2015, Molecular immunology.

[46]  Jiyu Li,et al.  Mast cell degranulation promotes ischemia-reperfusion injury in rat liver. , 2014, The Journal of surgical research.

[47]  N. Hogg,et al.  PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Mast cell and macrophage chemokines CXCL 1 / CXCL 2 control the early stage of neutrophil recruitment during tissue in fl ammation , 2013 .

[48]  甲田 賢一郎 Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells , 2012 .

[49]  K. Amin The role of mast cells in allergic inflammation. , 2012, Respiratory medicine.

[50]  K. Alysandratos,et al.  Mast cells and inflammation. , 2012, Biochimica et biophysica acta.

[51]  J. Roth,et al.  Expression of a mutant ER-retained polytope membrane protein in cultured rat hepatocytes results in Mallory body formation , 2001, Histochemistry and Cell Biology.

[52]  M. Tsai,et al.  Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. , 1995, International archives of allergy and immunology.

[53]  J. Scoazec,et al.  The cell adhesion molecules of hepatic sinusoidal endothelial cells. , 1994, Journal of hepatology.

[54]  H. Nord Complications of inflammatory bowel disease. , 1987, Hospital practice.

[55]  J. Exton The perfused rat liver. , 1975, Methods in enzymology.